Thakore, Pratiksha I.
Schnell, Alexandra http://orcid.org/0000-0003-3442-7750
Huang, Linglin
Zhao, Maryann http://orcid.org/0000-0001-9325-4066
Hou, Yu
Christian, Elena http://orcid.org/0000-0002-5593-0155
Zaghouani, Sarah http://orcid.org/0000-0002-4467-6542
Wang, Chao
Singh, Vasundhara http://orcid.org/0000-0001-8391-8527
Singaraju, Anvita http://orcid.org/0000-0002-3109-6354
Krishnan, Rajesh Kumar
Kozoriz, Deneen
Ma, Sai http://orcid.org/0000-0002-9785-7929
Sankar, Venkat
Notarbartolo, Samuele http://orcid.org/0000-0001-5910-4910
Buenrostro, Jason D. http://orcid.org/0000-0001-9958-3987
Sallusto, Federica http://orcid.org/0000-0003-3750-2752
Patsopoulos, Nikolaos A.
Rozenblatt-Rosen, Orit http://orcid.org/0000-0001-6313-3570
Kuchroo, Vijay K. http://orcid.org/0000-0001-7177-2110
Regev, Aviv http://orcid.org/0000-0003-3293-3158
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01NS045937, R01NS30843, R01AI144166)
Howard Hughes Medical Institute
Article History
Received: 20 May 2022
Accepted: 18 June 2024
First Online: 15 July 2024
Competing interests
: A.R. is a cofounder of and equity holder in Celsius Therapeutics, an equity holder in Immunitas and was a Scientific Advisory Board member of Thermo Fisher Scientific, Syros Pharmaceuticals, Neogene Therapeutics and Asimov until 31 July 2020. A.R. has been an employee of Genentech (member of the Roche Group) since August 2020. From 22 March 2021, P.I.T. has been an employee of Genentech. A.R. and P.I.T. have equity in Roche. From 19 October 2020, O.R.-R. has been an employee of Genentech and has equity in Roche. O.R.-R. is a co-inventor on patent applications filed by the Broad Institute for inventions related to single-cell genomics. She has given numerous lectures on the subject of single-cell genomics to a wide variety of audiences and, in some cases, has received remuneration to cover time and costs. V.K.K. is also a cofounder of, has an ownership interest in and is a member of the Scientific Advisory Board for Celsius Therapeutics, Tizona Therapeutics, Bicara Therapeutics and Larkspur Biosciences. The financial interests and conflicts of V.K.K. are managed by Brigham and Women’s Hospital and Partners Health Care system. None of these companies provided support for this work. J.D.B. holds patents related to ATAC-seq and is a Scientific Advisory Board member of Camp4 and seqWell. The other authors declare no competing interests.